JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Clinical Impact ofTurkish journal of haematology : official journal of Turkish Society of Haematology · 2023
   Article
2. The Contribution ofInternational journal of molecular sciences · 2022
   Review
3. Correlation analysis between JAK2, MPL, and CALR mutations in patients with myeloproliferative neoplasms of Chinese Uygur and Han nationality and their clinical characteristics.The Journal of international medical research · 2018
   Article
4. Impact of JAK2V617F Mutation Burden on Disease Phenotype in Chinese Patients with JAK2V617F-positive Polycythemia Vera (PV) and Essential thrombocythemia (ET).International journal of medical sciences · 2016
   Article
5. [JAK2 V617F mutation burden and its clinical implications in 415 patients with myeloproliferative neoplasm].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2015
   Article
6. The Burden of JAK2V617F Mutated Allele in Turkish Patients With Myeloproliferative Neoplasms.Journal of clinical medicine research · 2015
   Article
7. Genetic association between germline JAK2 polymorphisms and myeloproliferative neoplasms in Hong Kong Chinese population: a case-control study.BMC genetics · 2014
   Article
8. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?Disease models & mechanisms · 2014
   Review
9. Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.Haematologica · 2014
   Article
10. Inherited predisposition to myeloproliferative neoplasms.Therapeutic advances in hematology · 2013
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

15 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as